SCAAR Data Shows Edge For Taxus DES In Diabetics; More Studies Needed
This article was originally published in The Gray Sheet
Executive Summary
Data from a Swedish registry suggest paclitaxel-eluting stents are more effective than their competitors in diabetic patients, but the results need to be confirmed in prospective randomized trials, the authors conclude